In This Section      
 

Emergency Response IRB

In early March 2020, at the beginning of the COVID-19 pandemic in the United States, the JHM Office of Human Subjects Research began to strategize ways to review COVID-19 related research in a timely and systematic manner. To support the effort, a group of experts drawn from the existing JHM IRB membership were formulated to review COVID-19 related research.

JHM IRB 3 along with experts drawn from the other JHM committees who serve as alternates for JHM IRB 3 members meet regularly as the Emergency Response IRB.

The members have expertise in a number of areas including infectious diseases, pharmacy and therapeutics, research ethics and general internal medicine. The Emergency Response IRB is dedicated to the review of COVID-19 related new protocol applications, and change in research applications for currently approved research adding some aspect of COVID-19 related research.

The members of the Emergency Response IRB are:

Richard Moore, MD
Chairman
Professor of Internal Medicine

Mary Catherine Beach, M.D.,M.P.H.
Ethicist
Professor, Division of General Internal Medicine

Roy Brower, M.D
Professor, Pulmonary

Reverend Charles Goods
Unaffiliated/Non-Scientific Member

Bhakti Hansoti, MBCHB, MPH, PHD
Assistant Professor, Emergency Medicine

Craig Hendrix, M.D.
P & T Committee
Professor, Clinical Pharmacology

Joseph Carrese, M.D.
Ethicist
Professor, Medicine Division of General Internal Medicine

Reverend Calvin Keene
Unaffiliated Member/Non-Scientific Member

Howard Lederman M.D., Ph.D.
Professor, Pediatrics & Medicine

Verena Jorgensen, M.D.
Pediatric Endocrinology

Jonathan Zenilman, M.D.
Professor, Infectious Diseases

Last Updated 7/1/2021